Texas 2023 - 88th Regular

Texas House Bill HB3774

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to civil and criminal liability for pharmacists and pharmacies that dispense misoprostol.

Summary

House Bill 3774 aims to limit the civil and criminal liability for pharmacists and pharmacies that dispense misoprostol as prescribed by a physician for the treatment of medical conditions. The bill establishes that pharmacists are not liable for dispensing this medication if at least one prescribed use is legal under Texas state law, irrespective of other uses that may be illegal. By emphasizing the legal protection afforded to pharmacists, the bill seeks to ensure that they can provide necessary health services without fear of legal repercussions when adhering to medical guidelines. The sentiment towards HB3774 generally appears to lean positively among proponents who argue it provides critical legal protections for pharmacists involved in the treatment of patients. By clarifying the legal status around misoprostol, supporters believe that the bill might encourage pharmacists to dispense the medication more freely without the risk of liability, thereby improving patient care regarding conditions that require such treatment. This protective measure is seen as a necessary step for both healthcare providers and patients who depend on specific medications for their health needs. However, the bill has not been without controversy. Opponents of HB3774 express concerns about the implications of limiting liability in the context of medications that may have serious side effects or that are potentially misused. Critics worry that reducing liability may lead to lax oversight and could compromise patient safety. The debate hinges on the balance between ensuring access to necessary medications and maintaining stringent standards to safeguard public health. If enacted, HB 3774 would reshape the landscape of pharmaceutical dispensing laws in Texas, specifically concerning liability related to misoprostol. Its passage is likely to signify a shift towards a more pharmacist-friendly legal environment, ultimately impacting pharmacy practice and patient access to crucial medications. The bill reflects ongoing discussions regarding the role of pharmacists, the scope of their responsibilities, and the legal protections necessary for them to operate effectively and safely in a rapidly evolving healthcare landscape.

Companion Bills

No companion bills found.

Previously Filed As

TX SB01102

An Act Concerning Pharmacies And Pharmacists.

TX HB226

Pharmacies/pharmacists/benefits Managers

TX SB121

Pharmacies/pharmacists/benefits Managers

TX SB460

Relating to the licensing and regulation of pharmacists and pharmacies.

TX HB1358

Relating to procedures for certain audits of pharmacists and pharmacies.

TX SB591

Relating to procedures for certain audits of pharmacists and pharmacies.

TX HB426

Relative to the regulation of pharmacists-in-charge and pharmacies.

TX HB19

Relating to requirements for drugs dispensed by pharmacists.

TX SB683

Relating to the licensing and regulation of pharmacists and pharmacies.

TX HB2292

Relating to payment of claims to pharmacies and pharmacists.

Similar Bills

No similar bills found.